Amarin | AMRN - 当期純利益





当期純利益 変化する 日付
AbbVie USD 695M 1.12B 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amarin USD -1.22M 6.51M 2025-12
AstraZeneca USD 2.51B 573M 2026-06
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
DBV Technologies USD -47.6M 2.77M 2026-03
GlaxoSmithKline GBP 435M 1.3B 2026-06
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ionis Pharmaceuticals USD -93M 136M 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Novartis USD 3.26B 108M 2026-06